A phase I clinical-pharmacodynamic study of the farnesyltransferase inhibitor tipifarnib in combination with the proteasome inhibitor bortezomib in advanced acute leukemias (Q34629803)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase I clinical-pharmacodynamic study of the farnesyltransferase inhibitor tipifarnib in combination with the proteasome inhibitor bortezomib in advanced acute leukemias |
scientific article |
Statements
1 reference
A phase I clinical-pharmacodynamic study of the farnesyltransferase inhibitor tipifarnib in combination with the proteasome inhibitor bortezomib in advanced acute leukemias (English)
1 reference
Robert K Stuart
1 reference
Jeffrey E Lancet
1 reference
Vu H Duong
1 reference
Elliott F Winton
1 reference
Michelle Burton
1 reference
Shumin Zhang
1 reference
Christopher Cubitt
1 reference
Michelle A Blaskovich
1 reference
John J Wright
1 reference
Said Sebti
1 reference
Daniel M Sullivan
1 reference
13 January 2011
1 reference
1 reference
17
1 reference
5
1 reference
1140-1146
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference